Implication of complement system and its regulators in Alzheimer's disease.

Kolev, Martin V; Ruseva, Marieta M; Harris, Claire L; Morgan, B Paul; Donev, Rossen M

Kolev, Martin V; Ruseva, Marieta M; Harris, Claire L; Morgan, B Paul; Donev, Rossen M.

Afiliação

Kolev MV; Department of Medical Biochemistry and Immunology, School of Medicine, Heath Park, Cardiff University, Cardiff CF14 4XN, UK.

Curr Neuropharmacol ; 7(1): 1-8, 2009 Mar.

Article em En | MEDLINE | ID: mdl-19721814

Palavras-chave

Alzheimer's disease; CD59; complement; complement regulators; complement therapeutics.; inflammation; neurodegeneration; ß-amyloid peptide

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724661
https://dx.doi.org/10.2174/157015909787602805

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724661
https://dx.doi.org/10.2174/157015909787602805

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2009 Tipo de documento: Article